A detailed history of Inscription Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Inscription Capital, LLC holds 4,831 shares of NVO stock, worth $330,971. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,831
Previous 2,526 91.25%
Holding current value
$330,971
Previous $300,000 11.67%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 17, 2025

BUY
$69.3 - $90.95 $159,736 - $209,639
2,305 Added 91.25%
4,831 $335,000
Q3 2024

Oct 24, 2024

SELL
$119.07 - $145.42 $87,992 - $107,465
-739 Reduced 22.63%
2,526 $300,000
Q2 2024

Jul 17, 2024

SELL
$122.71 - $146.91 $192,163 - $230,061
-1,566 Reduced 32.42%
3,265 $466,000
Q1 2024

Jul 17, 2024

BUY
$102.11 - $135.92 $493,293 - $656,629
4,831 New
4,831 $620,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $155B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Inscription Capital, LLC Portfolio

Follow Inscription Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.